Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03172520 · ClinicalTrials.gov registry record · NA
Automatic Periodic Stimulation and Continuous Electromyography (EMG) for Facial Nerve Monitoring During Parotidectomy
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03172520: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT03172520 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03172520, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to document the safety of the Medtronic automatic periodic stimulating (APS) Electrode Stimulator during a parotidectomy and potentially prevent post-operative facial nerve weakness, which is a relatively common outcome after parotid surgery.
Interventions
- DEVICE APS electrode
- DEVICE Facial Nerve Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2017-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03172520
The ClinicalTrials.gov registry entry for NCT03172520 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which APS electrode is the first listed.
NCT03172520 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03172520 about?
NCT03172520 is a clinical study titled "Automatic Periodic Stimulation and Continuous Electromyography (EMG) for Facial Nerve Monitoring During Parotidectomy". The purpose of this study is to document the safety of the Medtronic automatic periodic stimulating (APS) Electrode Stimulator during a parotidectomy and potentially prevent post-operative facial nerve weakness, which is a relatively common outcome after parotid surgery.
What is the current status of trial NCT03172520?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2017-01-01. Estimated completion is 2017-12-30.
What interventions are being tested in trial NCT03172520?
The interventions under investigation include: APS electrode (DEVICE), Facial Nerve Monitor (DEVICE).
Who is sponsoring clinical trial NCT03172520?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.